Initial public offering

DIGITAL ALLY PRICES $5.1 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Tuesday, June 2, 2020 - 12:43pm

In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 463,636 shares of common stock offered in the public offering to cover over-allotments, if any.

Key Points: 
  • In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 463,636 shares of common stock offered in the public offering to cover over-allotments, if any.
  • Digital Ally , headquartered in Lenexa, KS, specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software.
  • Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security.
  • For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here:

RenaissanceRe Announces Public Offering of 5,500,000 Common Shares

Tuesday, June 2, 2020 - 12:24pm

RenaissanceRe Holdings Ltd. (NYSE: RNR) (the Company or RenaissanceRe) announced today that it has commenced an underwritten public offering of 5,500,000 of its common shares.

Key Points: 
  • RenaissanceRe Holdings Ltd. (NYSE: RNR) (the Company or RenaissanceRe) announced today that it has commenced an underwritten public offering of 5,500,000 of its common shares.
  • State Farm Mutual Automobile Insurance Company (State Farm), which currently owns approximately 4.4% of RenaissanceRes total common shares outstanding, has entered into an investment agreement to purchase, subject to the consummation of the underwritten public offering and other customary conditions, approximately $75 million of the Companys common shares at the public offering price per share in a concurrent private placement exempt from the registration requirements of the U.S. Securities Act of 1933, as amended.
  • Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and representatives of the underwriters for the offering.
  • The underwriters will have the option to purchase up to an aggregate of 825,000 additional common shares from the Company.

AudioCodes Announces Launch of Public Offering of Ordinary Shares

Tuesday, June 2, 2020 - 11:27am

LOD, Israel, June 2, 2020 /PRNewswire/ --AudioCodes (NASDAQ: AUDC) today announced the launch of an underwritten public offering of 2,600,000 ordinary shares pursuant to a registration statement on Form F-3 filed with the Securities and Exchange Commission ("SEC").

Key Points: 
  • LOD, Israel, June 2, 2020 /PRNewswire/ --AudioCodes (NASDAQ: AUDC) today announced the launch of an underwritten public offering of 2,600,000 ordinary shares pursuant to a registration statement on Form F-3 filed with the Securities and Exchange Commission ("SEC").
  • AudioCodes expects to grant the underwriters a 30-day option to purchase up to an additional 390,000 ordinary shares.
  • AudioCodes intends to use the proceeds from the offering for general corporate purposes, including, among other things, working capital requirements and possible future acquisitions.
  • AudioCodes has filed a preliminary prospectus supplement to its shelf registration statement on Form F-3 with the SEC for the proposed offering of its ordinary shares.

Vroom Announces Launch of Initial Public Offering

Tuesday, June 2, 2020 - 11:30am

Vroom, Inc. (Vroom), the online automotive retailer, today announced that it has commenced the initial public offering of its common stock.

Key Points: 
  • Vroom, Inc. (Vroom), the online automotive retailer, today announced that it has commenced the initial public offering of its common stock.
  • Vroom is offering 18,750,000 shares of its common stock.
  • The initial public offering price is expected to be between $15.00 and $17.00 per share.
  • Vroom expects to grant the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the initial public offering price to cover over-allotments.

Guardant Health Announces Pricing of Upsized Public Offering

Tuesday, June 2, 2020 - 3:32am

The public offering was increased from the previously announced offering size of 10,000,000 shares of common stock.

Key Points: 
  • The public offering was increased from the previously announced offering size of 10,000,000 shares of common stock.
  • In addition, Guardant Health and SoftBank Investment Advisers have granted the underwriter a 30-day option to purchase up to 1,725,000 additional shares of common stock (562,500 additional shares from Guardant Health and 1,162,500 additional shares from SoftBank Investment Advisers) at the public offering price, less underwriting discounts and commissions.
  • The gross proceeds from the offering to Guardant Health, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $315.0 million.
  • Guardant Health intends to use the net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by Guardant Health, primarily for general corporate purposes, including working capital, sales and marketing activities, general and administrative matters and capital expenditures.

Invitation Homes Prices Equity Offering

Tuesday, June 2, 2020 - 3:47am

Invitation Homes Inc. (NYSE: INVH) ("Invitation Homes" or the "Company") announced today the pricing of an offering of 14,500,000 shares of Invitation Homes common stock.

Key Points: 
  • Invitation Homes Inc. (NYSE: INVH) ("Invitation Homes" or the "Company") announced today the pricing of an offering of 14,500,000 shares of Invitation Homes common stock.
  • The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $395 million.
  • As part of the offering, Invitation Homes has granted the underwriters a 30-day option to purchase up to an additional 2,175,000 shares of common stock.
  • Invitation Homes intends to use the net proceeds from the offering for general corporate purposes, which may include, without limitation, working capital, repayment of indebtedness, acquisitions and renovations of single-family properties and for related activities in accordance with its business strategy.

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

Tuesday, June 2, 2020 - 2:39am

PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 01, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Adaptimmune)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares (ADSs) at a price to the public of $11.00 per ADS.

Key Points: 
  • PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 01, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Adaptimmune)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares (ADSs) at a price to the public of $11.00 per ADS.
  • In connection with the offering, Adaptimmune has granted the underwriters a 30-day option to purchase up to an additional 3,075,000 ADSs at the public offering price.
  • The gross offering size for this offering is expected to be $225.5 million, excluding any exercise of the underwriters option to purchase additional ADSs.
  • Cowen and SVB Leerink are acting as joint book-running managers for the offering and Roth Capital Partners is acting as lead manager for the offering.

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Tuesday, June 2, 2020 - 2:05am

SOUTH SAN FRANCISCO, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the pricing of an underwritten public offering of 11,702,128 shares of its common stock at a price to the public of $47.00 per share.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the pricing of an underwritten public offering of 11,702,128 shares of its common stock at a price to the public of $47.00 per share.
  • The gross proceeds from this offering are expected to be approximately $550.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Allogene.
  • In addition, Allogene has granted the underwriters a 30-day option to purchase up to 1,755,319 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.
  • Goldman Sachs & Co. LLC, Jefferies LLC and Cowen and Company, LLC are acting as joint lead book-running managers for the offering.

DIGITAL ALLY ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Monday, June 1, 2020 - 11:48pm

In addition, the Company expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering solely to cover over-allotments, if any.

Key Points: 
  • In addition, the Company expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering solely to cover over-allotments, if any.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security.
  • For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here:

Clarivate Plc Announces Offering of Ordinary Shares

Monday, June 1, 2020 - 9:56pm

LONDON and PHILADELPHIA, June 1, 2020 /PRNewswire/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Clarivate intends to offer 14 million ordinary shares, and affiliated shareholders of Onex Corporation and Baring Private Equity Asia (BPEA) and certain other shareholders intend to offer 26 million ordinary shares in an underwritten public offering.

Key Points: 
  • LONDON and PHILADELPHIA, June 1, 2020 /PRNewswire/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Clarivate intends to offer 14 million ordinary shares, and affiliated shareholders of Onex Corporation and Baring Private Equity Asia (BPEA) and certain other shareholders intend to offer 26 million ordinary shares in an underwritten public offering.
  • Certain of the selling shareholders are expected to grant the underwriters an option to purchase up to 6 million additional ordinary shares.
  • Clarivate intends to use its net proceeds from the offering for general corporate purposes.
  • Clarivate will not receive any proceeds from the sale of ordinary shares by the selling shareholders.